Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2.

Saved in:
Bibliographic Details
Title: Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2.
Authors: Hevesi Z; Center for Brain Research, Department of Molecular Neurosciences, Medical University of Vienna, 1090 Vienna, Austria., Gerges DA; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria., Kapps S; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria., Freire R; Unidad de Investigacion, Hospital Universitario de Canarias-FIISC, 38320 La Laguna, Spain.; Instituto de Tecnologías Biomedicas, Universidad de La Laguna, 38320 La Laguna, Spain.; Universidad Fernando Pessoa Canarias, 35450 Las Palmas de Gran Canaria, Spain., Schmidt S; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria., Pollak DD; Center for Physiology and Pharmacology, Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, 1090 Vienna, Austria., Schmetterer K; Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria., Frey T; Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria., Lang R; Division of Endocrinology, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria., Winnicki W; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria., Schmidt A; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria., Harkany T; Center for Brain Research, Department of Molecular Neurosciences, Medical University of Vienna, 1090 Vienna, Austria.; Department of Neuroscience, Biomedicum 7D, Karolinska Institutet, 17177 Solna, Sweden., Wagner L; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
Source: Vaccines [Vaccines (Basel)] 2022 Mar 26; Vol. 10 (4). Date of Electronic Publication: 2022 Mar 26.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2076-393X
DOI:10.3390/vaccines10040516